COMMERCIALIZATION SOLUTIONS FOR THE ORTHOPEDIC INDUSTRY
AUGUST 2020 | VOLUME 1

In interviewing additive manufacturing suppliers and buyers, AMPOWER found that companies in the industry project the entire market to have a compound annual growth rate of +20% from 2019 to 2024.

Orthopedic suppliers have bolstered their vendor managed inventory services, providing OEMs product flexibility and transparency. Millstone, Micropulse and Elite-Medical talk about five-year trends.

President Andy Elsbury shares how bringing 3D printing in-house has helped the company with product development and manufacturing response, and positioned them for COVID recovery.
Sponsored

Carpenter Additive carried out a study to create a systematic framework to optimize additive manufacturing for Nitinol, focusing on multiple factors like stringent control of Nitinol chemistry.

Minimally invasive sacroiliac joint fusion is an increasingly common treatment for patients with low back pain, and represents a high-growth niche in spine.
Upcoming Webinar | August 26 at 10:00 am EST


This webinar will discuss the use of additive manufacturing (AM) for critical components for a successful Total Hip Surgery to allow for optimization for improved patient satisfaction. Showcasing animal studies that have demonstrated the optimal pore size for bone in-growth in addition to initial fixation, which with additive manufacturing can be printed and implemented into the part design. Register

Device companies are continually pressuring contract manufacturers to reduce costs. This case study shows how cannulated raw material can reduce launch time and improve manufacturing efficiency.

Product portfolio roadmapping is like taking a trip. Companies must decide where they're going and how they're going to get there in order to be successful.


The ePub is online now.

Enter promo code "ENEWS" at checkout and pay $0 for 5 issues.


The announcement is the latest news in the evolution of meetings in the COVID era. We offer a few resources on how to stay connected and updated until the in-person Annual Meeting in August 2021.
Did you miss it?

Orthopedics' mid-tier of companies includes 11 device players with revenue between $200 million and $500 million. These companies are diversified across orthopedics but collectively derive the bulk of their revenue from joint replacement. 

“If you think about it, some of the worst things you could ever contemplate, both capacity risks and demand risks, are all happening like a Jack-in-the-Box for industries across the world."
From the Archives:

Companies can gain even greater performance results through business plan deployment, a key next step in driving lean manufacturing improvements and results.
"As a start-up, [ORTHOWORLD's] market trends, data and informed analysis are vital inputs for decision making, especially in such volatile times."
---Bill Hill, Chief Executive Officer, Gyder Surgical

Copyright © 2020. All Rights Reserved.